Obesity and metabolic complications: Contribution of dehydroepiandrosterone and other steroid hormones

Journal of Endocrinology

Volumn 150, Issue SUPPL., 1996, Pages

  Tchernof, A ^a   Labrie, F ^a   Belanger A ^a   Despres J P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE;

ADIPOSE TISSUE; BODY FAT; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY RISK; FEMALE; HUMAN; LIPID METABOLISM; MALE; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; DEHYDROEPIANDROSTERONE; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; OBESITY; SEX HORMONE-BINDING GLOBULIN; VISCERA;

EID: 0029961215     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (97)

1. Amatruda JM, Livingston JN & Lockwood DN 1985 Cellular mechanism in selected states of insulin resistance, human obesity, glucocorticoid excess and chronic renal failure. Diabetes and Metabolism Reviews 3 293-317.
2. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WS & Krauss RM 1988 Low-density lipoprotein subclass patterns and risk of myocardial infarction Journal of the American Medical Association 260 1917-1921.
3. Barrett-Connor E & Khaw KT 1988 Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 78 539-545.
4. Barrett-Connor E, Khaw KT & Yen SSC 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. New England Journal of Medicine 315 1519-1524.
5. Bjorntorp P 1984 Hazards in subgroups of human obesity. European Journal of Clinical Investigation 14 239-241.
6. Björntorp P 1985 Obesity and the risk of cardiovascular disease. Annals of Clinical Research 17 3-9.
7. Bjorntorp P 1991 Metabolic implications of body fat distribution. Diabetes Care 14 1132-1143.
8. Bjorntorp P 1995 Endocrine abnormalities of obesity. Metabolism 44 (Suppl 3) 21-23.
9. Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Darne B & Guize L 1989 Increased risk of atherosclerosis in women after the menopause. British Medical Journal 298 1311.
10. Bray GA 1985 Complications of obesity. Annals of Internal Medicine 103 1052-1062
11. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF & Schaefer EJ 1992 Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis and Thrombosis 12 187-195.
12. Coresh J, Kwiterovich PO & Bachorik P 1993 Association of low density lipoprotein size, density and composition with premature coronary artery disease. Journal of Lipid Research 34 1687-1697.
13. Crampes F, Beauville M, Riviere D, Garrigues M & Lafontan M 1988 Lack of desensitization of catecholamine-induced lipolysis in fat cell from trained and sedentary women after physical exercise. Journal of Clinical Endocrinology and Metabolism 67 1011-1019.
14. Crouse JR, Parks JS & Schey HM 1985 Studies of low density lipoprotein molecular weight in human beings with coronary artery disease Journal of Lipid Research 26 566-574.
15. Dai WS, Gutai JP, Kuller LH, Laporte RE, Falvo Gerard L & Caggiula A 1984 Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in men. American Journal of Cardiology 53 1259-1263.
16. Deslypere JP, Verdonck L & Vermeulen A 1985 Fat tissue: a steroid reservoir and site of steroid metabolism Journal of Clinical Endocrinology and Metabolism 61 564-570.
17. Després JP, Moorjam S, Lupien PJ, Tremblay A, Nadeau A & Bouchard C 1990 Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis and Thrombosis 10 497-511.
18. Després JP, Prud'homme D, Pouliot MC, Tremblay A & Bouchard C 1991 Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. American Journal of Clinical Nutrition 54 471-477.
19. Deutscher S, Bates MW, Cames MJ, Laporte RE, Puntereri A & Taylor FH 1986 Determinants of lipid and lipoprotein level in elderly men Atherosclerosis 60 221-229.
20. Donahue RP, Abbot RD, Bloom E, Reed DM & Yano K 1987 Central obesity and coronary heart disease in men. The Lancet 1 821-824
21. Ducimetière P, Richard J & Cambien F 1986 The pattern of subcutaneous fat distribution m middle-aged men and the risk of coronary heart disease, the Paris prospective study. International Journal of Obesity 10 229-240.
22. Dunaif A, Segal KR, Futterweit W & Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1165-1174.
23. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M & Zurlo F 1986 Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. American Journal of Clinical Nutrition 44 739-746
24. Eschwège E, Richard JL & Thibult N 1985 Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels the Parts prospective study, ten years later. Hormonal and Metabolic Research 15 (Suppl) 41-46.
25. Evans DJ, Hoffmann RG, Kalkhoff RK & Kissebah AH 1983 Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. Journal of Clinical Endocrinology and Metabolism 57 304-310.
26. Fisher WR 1983 Heterogeneity of plasma low density lipoproteins manifestations of the physiologic phenomenon in man. Metabolism 32 283-291.
27. Fujioka S, Matsuzawa Y, Tokunaga K & Tarui S 1987 Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36 54-59.
28. Garrison RJ, Kannel WB, Stokes J III & Castelli WP 1987 Incidence and precursors of hypertension in young adults: the Framingham offspring study Preventive Medicine 16 235-251
29. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ & Shepherd J 1990 Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 83 59-67
30. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ & Shepherd J 1994 Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 106 241-253.
31. Gutai J, Laporte R, Kuller L, Dai W, Falvo-Gerard L & Caggiula A 1981 Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. American Journal of Cardiology 48 897-902.
32. Haffner SM, Stem MP, Mitchell BD, Hazuda HP & Patterson JK 1990 Incidence of type 2 diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body fat distribution. Diabetes 39 283-288.
33. Hämäläinen E, Adlercreutz H, Ehnolm C & Puska P 1986 Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men Metabolism 35 535-541.
34. Hautanen A, Manttan M, Manninen V, Tenkanen L, Huttunen JK, Frick MH & Adlercreutz H 1994 Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis 105 191-200.
35. Heller RF & Jacobs HS 1978 Coronary heart disease in relation to age, sex, and the menopause. British Medical Journal 1 472-474.
36. Heller RF, Wheeler MJ, Micallef J, Miller NE & Lewis B 1983 Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone binding globulin. Acta Endocrinologica 104 253-256.
37. Jaakkola O, Solakivi T, Tertov VV, Orekhov AN, Miettinen TA & Nikkan T 1993 Characteristics of low-density lipoprotein subtractions from patients with coronary artery disease. Coronary Artery Disease 4 379-385.
38. Jensen J, Nilas L & Christianson C 1990 Influence of the menopause in serum lipids and lipoproteins. Maturitas 12 321-331.
39. Kahn MF & Zumoff B 1990 Sex hormones and coronary disease: a review of the clinical studies. Steroids 55 330-352.
40. Kiel DP, Baron JA, Plymate SR & Chute CG 1989 Sex hormones and lipoprotein in men. American Journal of Medicine 87 35-39
41. Kissebah AH 1989 Health risk of obesity. Medical Clinics in North America 73 111-138.
42. Kissebah AH & Krakower GR 1994 Regional adiposity and morbidity. Physiological Reviews 74 761-811.
43. Kissebah AH, Vydelingum N & Murray R 1982 Relation of body fat distribution to metabolic complications of obesity Journal of Clinical Endocrinology and Metabolism 54 254-260.
44. Labrie F, Simard J, Luu-The V, Martel C, Labrie C, Zhao HF, Rhéaume E, Couët J & Breton N 1991 Expression of 3β-hydroxysteroid dehydrogenase/D5-D4 isomerase (3β-HSD) and 17β-hydroxysteroid dehydrogenase (17β-HSD) in adipose tissue. International Journal of Obesity 15 91-99.
45. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR & Lupien PJ 1995a Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study). American Journal of Cardiology 75 1189-1195.
46. Lamarche B, Després JP, Mauriège P, Cantin B, Dagenais GR, Moorjani S & Lupien PJ 1995b Hyperinsulinemia as an independent risk factor for ischemic heart disease: five-year prospective data from the Québec Cardiovascular Study (abstract) International Journal of Obesity 19 (suppl 2) 31.
47. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E & Sjöström L 1984 Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. British Medical Journal 289 1261-1263.
48. Larsson B, Svardsudd K, Welin L, Wilhemsen L, Björntorp P & Tibblin G 1984 Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913. British Medical Journal 288 1401-1404.
49. Leenen R, van der Kooy K, Seidell JC, Deurenberg P & Koppeschaar HP 1994 Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. Journal of Clinical Endocrinology and Metabolism 78 1515-1520.
50. Lemieux S, Prud'homme D, Bouchard C, Tremblay A & Després JP 1993 Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. American Journal of Clinical Nutrition 58 463-467.
51. Lichtenstein MJ, Yarnell JWG, Elwood PC, Beswick AD, Sweetnam PM, Marks V, Teale D & Riad-Fahmy D 1987 Sex hormones, insulin, lipids and prevalent ischemic heart disease. American Journal of Epidemiology 126 647-657.
52. Lingholm J, Winkel P, Brothagen W & Gyntelberg F 1982 Coronary risk factors and plasma sex hormones. American Journal of Medicine 73 648-651.
53. Lueprasitsakul P, Latour D & Longcope C 1990 Aromatase activity in human adipose tissue stromal cells: effect of growth factors Steroids 55 540-544
54. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mantari M, Heinonen OP & Frick MH 1992 Joint effects of triglyceride and LDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment Circulation 85 37-45
55. Marin P, Holmang S, Jonsson L, Sjöström L, Kvist H, Holm G, Lindstedt G & Björntorp P 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. International Journal of Obesity 16 991-997.
56. Marin P, Holmang S, Gustafsson C, Jonsson L, Kvist H, Elander A, Eldh J, Sjöström L, Holm G & Björntorp P 1993 Androgen treatment of abdominally obese men. Obesity Research 1 245-251.
57. Matthews KA, Meilahn E, Kuller LH, Hesley SF, Caggiula AW & Wing RR 1989 Menopause and risk factor for coronary heart disease. New England Journal of Medicine 321 641-646.
58. Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS & Kashyap ML 1983 Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery 12 1-23.
59. Mendoza SG, Zerpa A, Velazquez E, Schwarzenberg A, Hynd B, Kashyap ML, Laskarzewski P & Glueck CJ 1986 Sex hormones, lipids, lipoprotem cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationships International Journal of Obesity 10 427-441
60. Nestler JE & Strauss JF III 1991 Insulin as an effector of human ovarian and adrenal steroid metabolism Endocrinology and Metabolism Clinics of North America 20 807-823.
61. Nestler JE, Usiskin KS, Barlascini CO, Welty DF, Clore JN & Blackard WG 1989 Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. Journal of Clinical Endocrinology and Metabolism 69 1040-1046
62. Nestler JE, McClanahan MA, Clore JN & Blackard WG 1992 Insulin inhibits adrenal 17,20-lyase activity in man. Journal of Clinical Endocrinology and Metabolism 74 362-367.
63. Nordoy A, Aakvaag A & Thelle D 1979 Sex hormones and high density lipoproteins in healthy males. Atherosclerosis 34 431-436.
64. Ohlson LO, Larsson B, Svardsudd K, Welin L, Enksson H, Wilhemsen L, Bjömtorp P & Tibblin G 1985 The influence of body fat distribution on the incidence of diabetes mellitus: 13-5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34 1055-1058.
65. Olefsky JM 1975 Effect of dexamethasone on insulin binding, glucose transport and glucose oxidation of isolated rat adipocytes Journal of Clinical Investigation 56 1499-1508.
66. Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate AM, Fabbri R, Capelli M & Bortoluzzi L 1991 Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40 101-104.
67. Peiris AN, Mueller RA, Struve MF, Smith GA & Kissebah AH 1987 Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. Journal of Clinical Endocrinology and Metabolism 64 162-169.
68. Phillips GB 1977 Relationships between serum sex hormones and a glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proceedings of the National Academy of Sciences of the USA 74 1729-1733.
69. Phillips GB 1993a Relationship between serum sex hormones and the glucose-insulin-lipid defect m men with obesity. Metabolism 42 116-120
70. Phillips GB 1993b Relationship of serum sex hormones to coronary heart disease. Steroids 58 286-290.
71. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'homme D, Lupien PJ, Tremblay A & Bouchard C 1992 Visceral obesity in men, associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41 826-834.
72. Pyoralä K 1979 Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease, results from two population studies in Finland Diabetes Care 2 131-141.
73. Razay G, Heaton KW & Bolton CH 1992 Coronary heart disease risk factors in relation to the menopause. Quarterly Journal of Medicine New Series 85 889-896
74. Rebuffé-Scrive M, Marin P &. Björntorp P 1991 Effect of testosterone on abdominal adipose tissue in men. International Journal of Obesity 15 791-795.
75. Rosenberg L, Hennekens CH, Rosner B, Bélanger C, Rothnam KJ & Spelzer FE 1981 Early menopause and the risk of myocardial infarction American Journal of Obstetrics and Gynecology 139 47-51.
76. Schneider G, Kirschner MA, Berkowitz R & Ertel NH 1979 Increased estrogen production in obese men. Journal of Clinical Endocrinology and Metabolism 48 633-638
77. Seidell JC, Björncorp P, Sjoström L, Kvist H & Sannrstedt R 1990 Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 39 897-901.
78. Semmens J, Rouse I, Beilin LJ & Masarei JR 1983 Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women. Metabolism 32 428-432.
79. Shoupe D & Lobo RA 1984 The influence of androgens on insulin resistance. Fertility and Sterility 41 385-388.
80. Simon D, Preziosi P, Barrett-Connor E, Roger M, Saint Paul M, Nahoul K & Papoz L 1992 Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom study. Diabetologia 35 173-177.
81. Sims EAH & Berchtold P 1982 Obesity and hypertension: mechanisms and implications for management. Journal of the American Medical Association 247 49-52.
82. Sjoström L 1988 Measurement of fat distribution. In Fat Distribution During Growth and Later Health Outcomes, pp 43-65. Eds C Bouchard & FE Johnston. New York: Liss.
83. Smith S, Ravnikar VA & Barbieri RL 1987 Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertility and Sterility 48 72-77.
84. Stanick S, Dornfeld LP, Maxwell MH, Viosca SP & Korenman SG 1981 The effect of weight loss on reproductive hormones in obese men. Journal of Clinical Endocrinology and Metabolism 53 828-832.
85. Stefanick ML, Williams PT, Krauss RM, Terry RB, Vranizan KM & Wood PD 1987 Relationships of plasma estradiol, testosterone, and sex hormone-binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein subfractions in men. Journal of Clinical Endocrinology and Metabolism 64 723-729.
86. Stevenson JC, Crook D & Godsland IF 1993 Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 98 83-90.
87. Tchernof A, Labrie F, Bélanger A, Bouchard C, Prud'homme D, Moorjani S, Lupien PJ & Després JP 1994 Endogenous steroid hormones, visceral obesity and plasma lipoprotein levels in men. Atherosclerosis 109 122.
88. Tchernof A, Després JP, Bélanger A, Dupont A, Prud'homme D, Moorjant S, Lupien PJ & Labrie F 1995a Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 44 513-519.
89. Tchernof A, Després JP, Dupont A, Bélanger A, Nadeau A, Prud'homme D, Moorjani S, Lupien PJ & Labrie F 1995b Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Diabetes Care 18 292-299.
90. Tchernof A, Lamarche B, Prud'homme D, Nacleau A, Moorjani S, Labrie F, Lupien PJ & Despres JP 1996 The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19 629-637.
91. Tornvall P, Karpe F, Carlson LA & Hamsten A 1991 Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 90 67-80.
92. Usiskin KS, Butterworth S, Clore JN, Arad Y, Ginsberg HN, Blackard WG & Nestler JE 1990 Lack of effect of dehydroepiandrosterone in obese men. International Journal of Obesity 14 457-463.
93. Vague J 1947 La différenciation sexuelle: facteur déterminant des formes de l'obésité. Presse Médicale 30 339-340
94. Welborn TA & Wearne K 1979 Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2 154-160.
95. Yarnell JW, Beswick AD, Sweetnam PM & Riad Fahmy D 1993 Endogenous sex hormones and ischemic heart disease in men The Caerphilly prospective study. Arteriosclerosis and Thrombosis 13 517-520.
96. Yarnell JW, Sweetnam PM, Marks V, Teale JD & Bolton CH 1994 Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. British Heart Journal 71 293-296.
97. Zamboni M, Armellini F, Milani MP, DeMarchi M, Todesco T, Robbi R, Bergamo-Andreis IA & Bosello O 1992 Body fat distribution in pre- and post-menopausal women, metabolic and anthropometricvariables and their inter-relationships. International Journal of Obesity 16 495-504.